Xeomin® is the latest cosmetic injectable approved by the FDA
Xeomin® is the latest cosmetic injectable approved by the FDA to treat facial lines and wrinkles.
Xeomin®, like Botox® and Dysport®, are commonly used to treat dynamic wrinkles. Dynamic wrinkles include the forehead lines, fine lines around the eyes, and the furrows between the eyebrows. Xeomin® works by targeting the wrinkle causing facial muscles in order to eliminate these dynamic lines. Xeomin® can provide a very natural appearing and dramatic improvement in your appearance.
What is Xeomin®?
Xeomin® is a medically derived sub-unit of botulinum toxin type a called incobotulinum toxin a. Xeomin® weakens the muscles into which it is placed, improving the appearance of fine lines and wrinkles.
What is the difference between Xeomin®, Botox® and Dysport®?
On a molecular level, Xeomin® is different from Botox® and Dysport® in that it does not contain any protein additives when packaged. The potential benefit of this is mainly for the rare patient who stopped responding to Botox® treatments because of the development of antibodies to the proteins.
How does Xeomin® work?
Xeomin® works by weakening the muscles of facial expression that insert onto the surface of the skin. Weakening the pull of these muscles on the skin causes the visible wrinkles to flatten out. Over time, cumulative benefits are observed as the skin remodels without the negative influence of the wrinkle-creating facial muscles.